US3108117A
(en)
|
1959-02-12 |
1963-10-22 |
Mead Johnson & Co |
3-benzyl-1, 2-diloweralkyl-3-pyrrolidinols
|
US3778443A
(en)
*
|
1969-02-13 |
1973-12-11 |
Ciba Geigy Ag |
4-tetrahydro pyridyl,hydroxy alkyl pyrazoles
|
US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
US3845770A
(en)
*
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
GB1422263A
(en)
|
1973-01-30 |
1976-01-21 |
Ferrosan As |
4-phenyl-piperidine compounds
|
US3916899A
(en)
*
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
DE2701705A1
(de)
|
1976-01-28 |
1977-08-04 |
Sandoz Ag |
Neue organische verbindungen, ihre verwendung und herstellung
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
CA1146866A
(en)
*
|
1979-07-05 |
1983-05-24 |
Yamanouchi Pharmaceutical Co. Ltd. |
Process for the production of sustained release pharmaceutical composition of solid medical material
|
DE3438830A1
(de)
*
|
1984-10-23 |
1986-04-30 |
Rentschler Arzneimittel |
Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
DK0580860T4
(da)
*
|
1991-04-16 |
2005-03-21 |
Nippon Shinyaku Co Ltd |
Fremgangsmåde til fremstilling af en fast dispersion
|
US5817667A
(en)
*
|
1991-04-17 |
1998-10-06 |
University Of Georgia Research Foudation |
Compounds and methods for the treatment of cancer
|
US5187677A
(en)
|
1991-08-23 |
1993-02-16 |
Hewlett-Packard Company |
Waveform synthesizer through simulating multiplication
|
US5340591A
(en)
*
|
1992-01-24 |
1994-08-23 |
Fujisawa Pharmaceutical Co., Ltd. |
Method of producing a solid dispersion of the sparingly water-soluble drug, nilvadipine
|
JP3265680B2
(ja)
*
|
1992-03-12 |
2002-03-11 |
大正製薬株式会社 |
経口製剤用組成物
|
AU4444393A
(en)
*
|
1992-09-01 |
1994-03-10 |
Zeneca Limited |
Pyrrolidine derivatives
|
GB9310713D0
(en)
|
1993-05-24 |
1993-07-07 |
Zeneca Ltd |
Aryl substituted heterocycles
|
US6020346A
(en)
*
|
1995-01-12 |
2000-02-01 |
Glaxo Wellcome Inc. |
Piperidine derivatives having tachykinin antagonist activity
|
DE69634678T2
(de)
|
1995-01-23 |
2006-01-19 |
Daiichi Suntory Pharma Co., Ltd. |
Verbesserung oder heilung von durch ischämischen krankheiten hervorgerufenen symtomen und dafür verwendbare phenylpiperidinverbingungen
|
DE19504832A1
(de)
*
|
1995-02-14 |
1996-08-22 |
Basf Ag |
Feste Wirkstoff-Zubereitungen
|
DE19519496A1
(de)
|
1995-05-27 |
1996-11-28 |
Lau Matthias Dipl Ing |
Sauerstoffsensitives Einschichtsystem und Verfahren zur Anordnung des Systems
|
BR9610385A
(pt)
|
1995-09-07 |
1999-07-06 |
Hoffmann La Roche |
Novas 4-(oxalcoxifenil)-3-óxi-piperidinas para tratamento de insuficiência cardiáca e renal
|
US5792769A
(en)
|
1995-09-29 |
1998-08-11 |
3-Dimensional Pharmaceuticals, Inc. |
Guanidino protease inhibitors
|
EP0858457A1
(de)
|
1995-10-20 |
1998-08-19 |
Dr. Karl Thomae GmbH |
5-gliedrige heterocyclen, diese verbindungen enthaltende arzneimittel und deren verwendung sowie verfahren zu ihrer herstellung
|
EP0867183B1
(en)
|
1996-07-22 |
2004-10-06 |
Daiichi Suntory Pharma Co., Ltd. |
Arylpiperidinol and arylpiperidine derivatives and drugs containing the same
|
ATE236904T1
(de)
|
1996-07-25 |
2003-04-15 |
Merck Sharp & Dohme |
Substituierte triazolo-pyridazin-derivate als liganden von gaba-rezeptoren
|
US5880138A
(en)
|
1996-10-01 |
1999-03-09 |
Eli Lilly And Company |
NMDA receptor selective antagonists
|
PT901786E
(pt)
|
1997-08-11 |
2007-08-07 |
Pfizer Prod Inc |
Disperções farmacêuticas sólidas com biodisponibilidade melhorada
|
JP4345230B2
(ja)
|
1998-03-10 |
2009-10-14 |
小野薬品工業株式会社 |
カルボン酸誘導体およびその誘導体を有効成分として含有する薬剤
|
US6274735B1
(en)
*
|
1998-08-10 |
2001-08-14 |
Hoffmann-La Roche Inc. |
Process and intermediates for preparation of substituted piperidines
|
IT1303737B1
(it)
*
|
1998-11-11 |
2001-02-23 |
Smithkline Beecham Spa |
Derivati fenilpiperidinici procedimento per la loro preparazione eloro uso come ligandi del recettore orl-1.
|
US20030017528A1
(en)
*
|
1998-11-20 |
2003-01-23 |
Ruoping Chen |
Human orphan G protein-coupled receptors
|
EP1584683B1
(en)
|
1998-11-20 |
2007-07-11 |
Arena Pharmaceuticals, Inc. |
Human orphan g protein-coupled receptor RUP3
|
US6221660B1
(en)
*
|
1999-02-22 |
2001-04-24 |
Synaptic Pharmaceutical Corporation |
DNA encoding SNORF25 receptor
|
CN1364155A
(zh)
|
1999-03-15 |
2002-08-14 |
Axys药物公司 |
用作蛋白酶抑制剂的n-氰基甲基酰胺
|
GB9912416D0
(en)
*
|
1999-05-28 |
1999-07-28 |
Pfizer Ltd |
Compounds useful in therapy
|
US6015712A
(en)
|
1999-07-19 |
2000-01-18 |
Isis Pharmaceuticals Inc. |
Antisense modulation of FADD expression
|
AR035016A1
(es)
|
1999-08-25 |
2004-04-14 |
Takeda Chemical Industries Ltd |
Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
|
GB9923177D0
(en)
|
1999-09-30 |
1999-12-01 |
Pfizer Ltd |
Novel polypeptide
|
IL152925A
(en)
|
1999-10-21 |
2010-04-15 |
Pfizer |
Pharmaceutical preparations for the treatment of neurological disease containing an inhibitor of ring guanizine '3', 5 '- monophosphate phosphodiesterase 5 and one of gabapentin or pregabalin
|
YU51701A
(sh)
|
2000-07-28 |
2003-12-31 |
Pfizer Inc. |
Postupak za dobijanje jedinjenja pirazola/4,3-d/ pirimidin-7-ona i njihovih derivata
|
US6770645B2
(en)
*
|
2001-03-16 |
2004-08-03 |
Pfizer Inc. |
Pharmaceutically active compounds
|
US6784185B2
(en)
*
|
2001-03-16 |
2004-08-31 |
Pfizer Inc. |
Pharmaceutically active compounds
|
WO2002088101A2
(en)
|
2001-04-27 |
2002-11-07 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of bace
|
US20030003157A1
(en)
|
2001-06-06 |
2003-01-02 |
University Of Medicine & Dentistry Of New Jersey |
Collagen compositions and methods for making and using the same
|
US7262185B2
(en)
|
2001-08-08 |
2007-08-28 |
Takeda Chemical Industries Ltd. |
Benzazepine derivative, process for producing the same, and use
|
JP4383177B2
(ja)
|
2002-03-01 |
2009-12-16 |
スミスクライン ビーチャム コーポレーション |
hPPAR活性化剤
|
EP1500648A4
(en)
|
2002-04-25 |
2005-12-21 |
Sumitomo Pharma |
NEW PIPERIDINE DERIVATIVES
|
US7091232B2
(en)
|
2002-05-21 |
2006-08-15 |
Allergan, Inc. |
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
|
EP2277867B1
(en)
|
2002-07-15 |
2012-12-05 |
Symphony Evolution, Inc. |
Compounds, pharmaceutical compositions thereof and their use in treating cancer
|
US7084145B2
(en)
|
2002-10-25 |
2006-08-01 |
Pfizer Inc. |
Triazole compounds useful in therapy
|
GB0224919D0
(en)
|
2002-10-25 |
2002-12-04 |
Pfizer Ltd |
Triazole compounds useful in therapy
|
GB0230162D0
(en)
*
|
2002-12-24 |
2003-02-05 |
Metris Therapeutics Ltd |
Compounds useful in inhibiting angiogenesis
|
SI1606282T1
(sl)
|
2003-02-24 |
2009-04-30 |
Arena Pharm Inc |
Fenilni in piridilpiperidinski derivati kot modulatorji glukoznega metabolizma
|
DE60306690T2
(de)
|
2003-03-05 |
2007-06-28 |
Maus S.P.A. |
Verfahren zum bearbeiten von bremsscheiben
|
GB0308333D0
(en)
|
2003-04-10 |
2003-05-14 |
Glaxo Group Ltd |
Novel compounds
|
EP1620405A2
(en)
|
2003-05-01 |
2006-02-01 |
Abbott Laboratories |
Pyrazole-amides and sulfonamides as sodium channel modulators
|
EP1620108B1
(en)
|
2003-05-01 |
2012-06-06 |
Bristol-Myers Squibb Company |
Pyrazole-amine compounds useful as kinase inhibitors
|
US20040220170A1
(en)
|
2003-05-01 |
2004-11-04 |
Atkinson Robert N. |
Pyrazole-amides and sulfonamides as sodium channel modulators
|
KR20060009390A
(ko)
|
2003-06-13 |
2006-01-31 |
쉐링 악티엔게젤샤프트 |
Ccr-5 길항제로서의 퀴놀릴 아미드 유도체
|
AR045697A1
(es)
|
2003-07-14 |
2005-11-09 |
Arena Pharm Inc |
Aril y heteroaril derivados fusionados como moduladores del metabolismo y la prevencion y tratamiento de trastornos relacionados con el mismo
|
CN1829718A
(zh)
*
|
2003-07-14 |
2006-09-06 |
艾尼纳制药公司 |
作为新陈代谢调节剂的稠合芳基和杂芳基衍生物以及预防和治疗与其相关的病症
|
SG145695A1
(en)
|
2003-07-29 |
2008-09-29 |
Xenon Pharmaceuticals Inc |
Pyridyl derivatives and their use as therapeutic agents
|
FR2862647B1
(fr)
*
|
2003-11-25 |
2008-07-04 |
Aventis Pharma Sa |
Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant
|
US7235641B2
(en)
|
2003-12-22 |
2007-06-26 |
Micromet Ag |
Bispecific antibodies
|
WO2005061489A1
(en)
|
2003-12-24 |
2005-07-07 |
Prosidion Limited |
Heterocyclic derivatives as gpcr receptor agonists
|
TW200538433A
(en)
|
2004-02-24 |
2005-12-01 |
Irm Llc |
Immunosuppressant compounds and compositiions
|
JP4787529B2
(ja)
|
2004-04-09 |
2011-10-05 |
大塚製薬株式会社 |
医薬組成物
|
US20080306114A1
(en)
|
2004-04-13 |
2008-12-11 |
Arena Pharmaceuticals, Inc |
Human G Protein-Coupled Receptor and Modulators Thereof for the Treatment of Hyperglycemia and Related Disorders
|
DE102004020186A1
(de)
|
2004-04-22 |
2005-11-17 |
Aventis Pharma Deutschland Gmbh |
Heterocyclylessigsäuren als Inhibitoren von TAFla
|
US8710232B2
(en)
|
2004-04-22 |
2014-04-29 |
Sanofi-Aventis Deutschland Gmbh |
Imidazole derivatives used as TAFIa inhibitors
|
CA2569843A1
(en)
|
2004-06-08 |
2005-12-22 |
A. Carlsson Research Ab |
New disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission
|
US8329913B2
(en)
|
2004-10-29 |
2012-12-11 |
Zeria Pharmaceutical Co., Ltd. |
Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof
|
TW200633990A
(en)
|
2004-11-18 |
2006-10-01 |
Takeda Pharmaceuticals Co |
Amide compound
|
JPWO2006057448A1
(ja)
|
2004-11-26 |
2008-06-05 |
武田薬品工業株式会社 |
アリールアルカン酸誘導体
|
GB0428526D0
(en)
|
2004-12-30 |
2005-02-09 |
Novartis Ag |
Organic compounds
|
ATE519759T1
(de)
|
2004-12-30 |
2011-08-15 |
Exelixis Inc |
Pyrimidinderivate als kinasemodulatoren und anwendungsverfahren
|
WO2006073167A1
(ja)
|
2005-01-07 |
2006-07-13 |
Ono Pharmaceutical Co., Ltd. |
ピロリジン誘導体
|
DOP2006000008A
(es)
|
2005-01-10 |
2006-08-31 |
Arena Pharm Inc |
Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
|
MY148521A
(en)
*
|
2005-01-10 |
2013-04-30 |
Arena Pharm Inc |
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
|
US8277495B2
(en)
|
2005-01-13 |
2012-10-02 |
Candela Corporation |
Method and apparatus for treating a diseased nail
|
CN101189225A
(zh)
|
2005-02-16 |
2008-05-28 |
先灵公司 |
具有cxcr3拮抗剂活性的杂芳基取代的吡嗪基-哌嗪-哌啶
|
GB0504850D0
(en)
|
2005-03-09 |
2005-04-13 |
Novartis Ag |
Organic compounds
|
US20060206074A1
(en)
|
2005-03-11 |
2006-09-14 |
The Procter & Gamble Company |
Absorbent core structures having undulations
|
EP1707202A1
(de)
|
2005-03-31 |
2006-10-04 |
Speedel Experimenta AG |
Organische Verbindungen
|
KR100712289B1
(ko)
|
2005-04-07 |
2007-04-27 |
삼성에스디아이 주식회사 |
평판표시장치 및 그의 제조방법
|
JP2008540656A
(ja)
|
2005-05-18 |
2008-11-20 |
ワイス |
Tpl2キナーゼの3−シアノキノリン阻害物質ならびにそれを製造および使用する方法
|
US20090170907A1
(en)
|
2005-06-06 |
2009-07-02 |
Smithkline Beecham Corporation |
Chemical Compounds
|
CA2611216A1
(en)
|
2005-06-15 |
2006-12-21 |
Pfizer Limited |
3-phenylazetidine derivatives as dopamine agonists
|
EP1912980A2
(en)
|
2005-06-20 |
2008-04-23 |
Wockhardt Limited |
Oxazolidinones bearing antimicrobial activity composition and methods of preparation
|
WO2007003961A2
(en)
|
2005-06-30 |
2007-01-11 |
Prosidion Limited |
Gpcr agonists
|
WO2007003960A1
(en)
|
2005-06-30 |
2007-01-11 |
Prosidion Limited |
Gpcr agonists
|
TW200738701A
(en)
|
2005-07-26 |
2007-10-16 |
Du Pont |
Fungicidal carboxamides
|
JP2007045752A
(ja)
|
2005-08-10 |
2007-02-22 |
Takeda Chem Ind Ltd |
5員芳香族複素環誘導体、その製造法および用途
|
EP1931654B1
(en)
|
2005-09-16 |
2009-04-22 |
Arena Pharmaceuticals, Inc. |
Modulators of metabolism and the treatment of disorders related thereto
|
BRPI0617207A2
(pt)
|
2005-09-29 |
2011-07-19 |
Sanofi Aventis |
derivados de fenil-1,2,4-oxadiazolona, processos para sua preparação e seu uso como produtos farmacêuticos
|
JP5201817B2
(ja)
|
2005-10-28 |
2013-06-05 |
大塚製薬株式会社 |
医薬組成物
|
PE20071221A1
(es)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
|
FR2902767B1
(fr)
|
2006-06-22 |
2008-09-19 |
J P B Creations Sa |
Dispositif de conditionnement d'un produit a base de colle
|
US8119778B2
(en)
|
2006-06-23 |
2012-02-21 |
Basf Se |
Reversibly thermochromic compositions
|
JP2009543805A
(ja)
|
2006-07-13 |
2009-12-10 |
スミスクライン ビーチャム コーポレーション |
インドリン誘導体及びgpr119作動物質
|
EP2059516A1
(en)
|
2006-08-30 |
2009-05-20 |
BIOVITRUM AB (publ) |
Pyridine compounds for treating gpr119 related disorders
|
EP2325182A1
(en)
|
2006-12-06 |
2011-05-25 |
Glaxosmithkline LLC |
Bicyclic compounds and use as antidiabetics
|
MX2009006234A
(es)
|
2006-12-11 |
2009-06-22 |
Wyeth Corp |
Moduladores del canal de ion.
|
WO2008073936A1
(en)
|
2006-12-11 |
2008-06-19 |
Wyeth |
Carboxamide derivatives as ion channel modulators
|
CN101594862B
(zh)
|
2006-12-20 |
2015-11-25 |
内尔维阿诺医学科学有限公司 |
作为激酶抑制剂的取代吲唑衍生物
|
CN101616586B
(zh)
|
2006-12-28 |
2014-08-13 |
赛马拜制药公司 |
治疗糖尿病和代谢性病症的杂环受体激动剂
|
US7638541B2
(en)
*
|
2006-12-28 |
2009-12-29 |
Metabolex Inc. |
5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
|
ES2352880T3
(es)
|
2007-03-08 |
2011-02-23 |
Irm Llc |
Compuestos y composiciones como moduladores de la actividad de gpr119.
|
ES2388315T3
(es)
|
2007-05-04 |
2012-10-11 |
Bristol-Myers Squibb Company |
Agonistas [6,5]-bicíclicos de receptores GPR119 acoplados a la proteína G
|
US20110046137A1
(en)
|
2007-05-10 |
2011-02-24 |
Glaxo Group Limited |
Pyrazole Derivatives as P2X7 Modulators
|
EP2014656A3
(en)
|
2007-06-11 |
2011-08-24 |
High Point Pharmaceuticals, LLC |
New heteocyclic h3 antagonists
|
ES2435779T3
(es)
|
2007-07-19 |
2013-12-23 |
Sanofi |
Agentes citotóxicos que comprenden nuevos derivados de tomaimicina y su uso terapéutico
|
FR2918986B1
(fr)
|
2007-07-19 |
2009-09-04 |
Sanofi Aventis Sa |
Derives de 6-cycloamino-3-(pyridazin-4-yl)imidazo[1,2-b]- pyridazine, leur preparation et leur application en therapeutique
|
AU2008277796A1
(en)
|
2007-07-19 |
2009-01-22 |
F. Hoffmann-La Roche Ag |
Novel heterocyclyl compounds and their use as chemokine antagonists
|
AR067585A1
(es)
|
2007-07-19 |
2009-10-14 |
Schering Corp |
Compuestos heterociclicos de amidas como inhibidores de la proteincinasa
|
WO2009014910A2
(en)
|
2007-07-19 |
2009-01-29 |
Metabolex, Inc. |
N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the rup3 or gpr119 receptor for the treatment of diabetes and metabolic disorders
|
UY31232A1
(es)
|
2007-07-19 |
2009-03-02 |
|
Compuestos derivados de dibenzotifenilamino-cromen-4-onas activas sustituidas y sus isomeros y aplicaciones
|
US20100249163A1
(en)
|
2007-12-04 |
2010-09-30 |
Daniel Dube |
Renin inhibitors
|
EP2280704B1
(en)
*
|
2008-03-31 |
2015-05-13 |
Cymabay Therapeutics, Inc. |
Oxymethylene aryl compounds and uses thereof
|
US8188098B2
(en)
*
|
2008-05-19 |
2012-05-29 |
Hoffmann-La Roche Inc. |
GPR119 receptor agonists
|
JP2011524917A
(ja)
|
2008-06-20 |
2011-09-08 |
メタボレックス, インコーポレイテッド |
アリールgpr119作動薬およびその使用
|
WO2010013849A1
(ja)
|
2008-08-01 |
2010-02-04 |
日本ケミファ株式会社 |
Gpr119作動薬
|
US8513264B2
(en)
*
|
2008-09-10 |
2013-08-20 |
Boehringer Ingelheim International Gmbh |
Combination therapy for the treatment of diabetes and related conditions
|
WO2010048149A2
(en)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
US20110160222A1
(en)
*
|
2008-11-26 |
2011-06-30 |
Metabolex, Inc. |
Modulators of glucose homeostasis for the treatment of diabetes and metabolic disorders
|
ES2497566T3
(es)
|
2009-10-01 |
2014-09-23 |
Cymabay Therapeutics, Inc. |
Sales de tetrazol-1-il-fenoximetil-tiazol-2-il-piperidinil-pirimidina sustituida
|
US20110313160A1
(en)
*
|
2010-06-04 |
2011-12-22 |
Metabolex, Inc. |
Preparation of 5-ethyl-2--pyrimidine
|
WO2011163090A1
(en)
*
|
2010-06-23 |
2011-12-29 |
Metabolex, Inc. |
Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
|
US20120184572A1
(en)
*
|
2011-01-13 |
2012-07-19 |
Metabolex, Inc. |
Aryl gpr119 agonists and uses thereof
|